001     62370
005     20180211181156.0
024 7 _ |a pmid:18949074
|2 pmid
024 7 _ |a pmc:PMC2570550
|2 pmc
024 7 _ |a 10.2174/1874091X00802010044
|2 DOI
037 _ _ |a PreJuSER-62370
041 _ _ |a eng
082 _ _ |a 540
100 1 _ |a Kastenholz, B.
|b 0
|u FZJ
|0 P:(DE-Juel1)129343
245 _ _ |a Phytochemical approach and bioanalytical strategy to develop chaperone-based medications
260 _ _ |a Sharjah [u.a.]
|b Bentham Open
|c 2008
300 _ _ |a 44 - 48
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a The Open Biochemistry Journal
|x 1874-091X
|0 18801
|v 2
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Currently, no pharmaceuticals for the etiological treatment of degenerative protein-misfolding diseases (e.g., ALS, Alzheimer's or prion diseases) are commercially available. In this technical note theoretical considerations and practical approaches concerning the development of chaperone-based medications from medicinal plants (e.g., Ginkgo biloba) are reviewed and discussed in detail. Phytochaperones and other agents isolated from medicinal plants are proposed to serve as the general basis of drug development in protein-misfolding diseases.
536 _ _ |a Terrestrische Umwelt
|c P24
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK407
|x 0
588 _ _ |a Dataset connected to Pubmed
773 _ _ |a 10.2174/1874091X00802010044
|g Vol. 2, p. 44 - 48
|p 44 - 48
|q 2<44 - 48
|0 PERI:(DE-600)2396170-3
|t The @open biochemistry journal
|v 2
|y 2008
|x 1874-091X
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570550
909 C O |o oai:juser.fz-juelich.de:62370
|p VDB
913 1 _ |k P24
|v Terrestrische Umwelt
|l Terrestrische Umwelt
|b Erde und Umwelt
|0 G:(DE-Juel1)FUEK407
|x 0
914 1 _ |y 2008
915 _ _ |0 StatID:(DE-HGF)0020
|a No peer review
920 1 _ |k ICG-3
|l Phytosphäre
|d 31.10.2010
|g ICG
|0 I:(DE-Juel1)ICG-3-20090406
|x 1
970 _ _ |a VDB:(DE-Juel1)98588
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)IBG-2-20101118
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBG-2-20101118
981 _ _ |a I:(DE-Juel1)ICG-3-20090406


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21